Freudenberg Performance Materials invests in technology for bioresorbable nonwovens

Freudenberg Performance Materials invested in specially-designed equipment to produce bioresorbable nonwovens for surgical hemostasis. The company plans to collaborate with partners to offer solutions for bioactive wound healing, drug release and regenerative medicine.

“Expanding our range of technologies to include bioresorbable nonwovens for use in managing surgical hemostasis brings our customers several benefits: the innovative solution is more effective than existing options, so it reduces costs and can, in some cases, even save lives.”freudenberg-pm.com

• 1 source
• freudenberg-pm.comFreudenberg Performance Materials invests in technology for bioactive nonwovensNov 25, 2024

Summarized from public sources; check the original articles before acting on it.